微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.45% | -51.61% | -15.09% | 50/69 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 0.53% | -43.62% | -55.46% | 52/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 1.19% | -65.61% | -25.16% | 46/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 1.59% | -40.89% | 70.97% | 54/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 0.93% | -45.29% | -1.06% | 50/69 | 0.62% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.94% | -28.79% | -72.83% | 50/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 3.46% | 11.61% | 28.62% | 47/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 2.69% | -5.94% | 58.24% | 55/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 1.7% | 8.97% | 28.79% | 54/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.32% | 1.54% | -57.42% | 54/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 3.1% | -24.76% | 8.39% | 48/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 2.86% | -10.63% | 83.33% | 52/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 1.56% | -12.36% | 20% | 54/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.3% | -5.8% | -68.45% | 48/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 4.12% | 22.99% | 28.75% | 49/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 3.2% | 15.52% | 79.78% | 55/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 1.78% | 24.48% | 28.99% | 57/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.38% | 24.32% | -58.81% | 52/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 3.35% | -0.59% | 20.94% | 48/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 2.77% | -5.78% | 93.71% | 55/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 1.43% | -26.67% | 28.83% | 53/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.11% | 21.98% | -67.06% | 50/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 3.37% | 8.36% | 14.63% | 50/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 2.94% | 1.03% | 50.77% | 50/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 1.95% | -5.8% | 114.29% | 51/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 0.91% | -18.75% | -70.74% | 56/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 3.11% | 13.92% | 6.87% | 54/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 2.91% | -9.91% | 40.58% | 53/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 2.07% | 38.93% | 84.82% | 51/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 1.12% | 10.89% | -58.97% | 49/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 2.73% | 1286.96% | -15.48% | 59/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 3.23% | 80.45% | 116.78% | 56/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 1.49% | 263.41% | 47.52% | 57/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.01% | 20.24% | 539.13% | 49/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | -0.23% | -560% | -112.85% | 61/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 1.79% | -55.58% | 336.59% | 54/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 0.41% | -85.86% | -51.19% | 58/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 0.84% | 3.7% | 1580% | 49/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 0.05% | -98.91% | -98.76% | 59/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 4.03% | 0.5% | 38.97% | 44/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 2.9% | 17.89% | 258.02% | 44/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 0.81% | -21.36% | -82.28% | 46/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |